{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T03:25:20Z","timestamp":1787282720550,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,20]]},"DOI":"10.7759\/cureus.114896","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T03:09:43Z","timestamp":1787281783000},"source":"Crossref","is-referenced-by-count":0,"title":["Peri-Coronary Adipose Tissue Attenuation and Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Sandeep","family":"Guntuku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyank","family":"Chokshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Karipineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dishant","family":"Rakholia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mounica","family":"Vorla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayana Varalakshmi","family":"Akula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vimala","family":"Thambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Lajczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad F","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"Eltawansy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev Vijay Kumar","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2012.11.003","article-title":"2012 focused update of the ESC guidelines for the management of atrial fibrillation","volume":"66","author":"Camm AJ","year":"2013","unstructured":"Camm AJ, Lip GYH, De Caterina R, et al.. 2012 focused update of the ESC guidelines for the management of atrial fibrillation. Rev Esp Cardiol (Engl Ed). 2013, 66:54. 10.1016\/j.rec.2012.11.003","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: the Framingham Heart Study","volume":"110","author":"Lloyd-Jones DM","year":"2004","unstructured":"Lloyd-Jones DM, Wang TJ, Leip EP, et al.. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004, 110:1042-6. 10.1161\/01.CIR.0000140263.20897.42","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa J","year":"2006","unstructured":"Heeringa J, van der Kuip DA, Hofman A, et al.. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006, 27:949-53. 10.1093\/eurheartj\/ehi825","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf PA","year":"1991","unstructured":"Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991, 22:983-8. 10.1161\/01.str.22.8.983","journal-title":"Stroke"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092510","article-title":"Atrial fibrillation and heart failure","volume":"11","author":"Bergau L","year":"2022","unstructured":"Bergau L, Bengel P, Sciacca V, Fink T, Sohns C, Sommer P. Atrial fibrillation and heart failure. J Clin Med. 2022, 11:10.3390\/jcm11092510","journal-title":"J Clin Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa258","article-title":"Pathophysiology of atrial fibrillation and chronic kidney disease","volume":"117","author":"Ding WY","year":"2021","unstructured":"Ding WY, Gupta D, Wong CF, Lip GY. Pathophysiology of atrial fibrillation and chronic kidney disease. Cardiovasc Res. 2021, 117:1046-59. 10.1093\/cvr\/cvaa258","journal-title":"Cardiovasc Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.11912","article-title":"Atrial fibrillation and the risk of myocardial infarction","volume":"174","author":"Soliman EZ","year":"2014","unstructured":"Soliman EZ, Safford MM, Muntner P, et al.. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med. 2014, 174:107-14. 10.1001\/jamainternmed.2013.11912","journal-title":"JAMA Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5830\/CVJA-2019-064","article-title":"Treatment of atrial fibrillation: a comprehensive review and practice guide","volume":"31","author":"Li J","year":"2020","unstructured":"Li J, Gao M, Zhang M, Liu D, Li Z, Du J, Hou Y. Treatment of atrial fibrillation: a comprehensive review and practice guide. Cardiovasc J Afr. 2020, 31:153-8. 10.5830\/CVJA-2019-064","journal-title":"Cardiovasc J Afr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-041316-090015","article-title":"Atrial fibrillation ablation","volume":"69","author":"Latchamsetty R","year":"2018","unstructured":"Latchamsetty R, Morady F. Atrial fibrillation ablation. Annu Rev Med. 2018, 69:53-63. 10.1146\/annurev-med-041316-090015","journal-title":"Annu Rev Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eus027","article-title":"2012 HRS\/EHRA\/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design","volume":"14","author":"Calkins H","year":"2012","unstructured":"Calkins H, Kuck KH, Cappato R, et al.. 2012 HRS\/EHRA\/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012, 14:528-606. 10.1093\/europace\/eus027","journal-title":"Europace"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12196313","article-title":"Inflammatory markers as predictors of atrial fibrillation recurrence: exploring the C-reactive protein to albumin ratio in cryoablation patients","volume":"12","author":"Ozkan E","year":"2023","unstructured":"Ozkan E, Elcik D, Barutcu S, et al.. Inflammatory markers as predictors of atrial fibrillation recurrence: exploring the C-reactive protein to albumin ratio in cryoablation patients. J Clin Med. 2023, 12:10.3390\/jcm12196313","journal-title":"J Clin Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13499","article-title":"BMI and atrial fibrillation recurrence post catheter ablation: a dose-response meta-analysis","volume":"51","author":"Pranata R","year":"2021","unstructured":"Pranata R, Henrina J, Yonas E, et al.. BMI and atrial fibrillation recurrence post catheter ablation: a dose-response meta-analysis. Eur J Clin Invest. 2021, 51:e13499. 10.1111\/eci.13499","journal-title":"Eur J Clin Invest"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2010.215335","article-title":"Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation","volume":"97","author":"den Uijl DW","year":"2011","unstructured":"den Uijl DW, Delgado V, Bertini M, et al.. Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation. Heart. 2011, 97:1847-51. 10.1136\/hrt.2010.215335","journal-title":"Heart"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4022\/jafib.935","article-title":"Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data","volume":"6","author":"Phillips KP","year":"2013","unstructured":"Phillips KP. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Atr Fibrillation. 2013, 6:935. 10.4022\/jafib.935","journal-title":"J Atr Fibrillation"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/clc.24081","article-title":"Impact of pericoronary adipose tissue attenuation on recurrence after radiofrequency catheter ablation for atrial fibrillation","volume":"46","author":"Wang Z","year":"2023","unstructured":"Wang Z, Wang YJ, Chen JW, et al.. Impact of pericoronary adipose tissue attenuation on recurrence after radiofrequency catheter ablation for atrial fibrillation. Clin Cardiol. 2023, 46:1244-52. 10.1002\/clc.24081","journal-title":"Clin Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20210361","article-title":"Association between pericoronary adipose tissue attenuation and outcome after second-generation cryoballoon ablation for atrial fibrillation","volume":"94","author":"Nogami K","year":"2021","unstructured":"Nogami K, Sugiyama T, Kanaji Y, et al.. Association between pericoronary adipose tissue attenuation and outcome after second-generation cryoballoon ablation for atrial fibrillation. Br J Radiol. 2021, 94:20210361. 10.1259\/bjr.20210361","journal-title":"Br J Radiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref18","article-title":"Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5","author":"Higgins JPT","year":"2000","unstructured":"Higgins JPT, Thomas J, Chandler J, et al.. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5. Cochrane, 2000."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-023-01426-x","article-title":"Association of pericoronary adipose tissue with atrial fibrillation recurrence after ablation based on computed tomographic angiography","volume":"41","author":"Ma GJ","year":"2023","unstructured":"Ma GJ, Guo FQ, Hu J, Liu XW, Chen C, Gao B, Li CY. Association of pericoronary adipose tissue with atrial fibrillation recurrence after ablation based on computed tomographic angiography. Jpn J Radiol. 2023, 41:955-64. 10.1007\/s11604-023-01426-x","journal-title":"Jpn J Radiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan X","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014, 14:135. 10.1186\/1471-2288-14-135","journal-title":"BMC Med Res Methodol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne JA","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al.. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016, 355:i4919. 10.1136\/bmj.i4919","journal-title":"BMJ"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127111","article-title":"Obesity, metabolic syndrome and risk of atrial fibrillation: a Swedish, prospective cohort study","volume":"10","author":"Nystr\u00f6m PK","year":"2015","unstructured":"Nystr\u00f6m PK, Carlsson AC, Leander K, de Faire U, Hellenius ML, Gigante B. Obesity, metabolic syndrome and risk of atrial fibrillation: a Swedish, prospective cohort study. PLoS One. 2015, 10:e0127111. 10.1371\/journal.pone.0127111","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.08.060","article-title":"Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation","volume":"49","author":"Gami AS","year":"2007","unstructured":"Gami AS, Hodge DO, Herges RM, Olson EJ, Nykodym J, Kara T, Somers VK. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol. 2007, 49:565-71. 10.1016\/j.jacc.2006.08.060","journal-title":"J Am Coll Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ipej.2024.12.005","article-title":"The importance of inflammation in atrial fibrillation recurrence in patients with atrial fibrillation treated with Cryo balloon ablation","volume":"25","author":"Elcik D","year":"2025","unstructured":"Elcik D, Tuncay A, Bireciklioglu MF, \u0130nanc MT. The importance of inflammation in atrial fibrillation recurrence in patients with atrial fibrillation treated with Cryo balloon ablation. Indian Pacing Electrophysiol J. 2025, 25:14-9. 10.1016\/j.ipej.2024.12.005","journal-title":"Indian Pacing Electrophysiol J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2015.2","article-title":"Inflammation and the pathogenesis of atrial fibrillation","volume":"12","author":"Hu YF","year":"2015","unstructured":"Hu YF, Chen YJ, Lin YJ, Chen SA. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015, 12:230-43. 10.1038\/nrcardio.2015.2","journal-title":"Nat Rev Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2143\/AC.56.6.2005701","article-title":"C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation","volume":"56","author":"Dernellis J","year":"2001","unstructured":"Dernellis J, Panaretou M. C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol. 2001, 56:375-80. 10.2143\/AC.56.6.2005701","journal-title":"Acta Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eun309","article-title":"Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation","volume":"11","author":"Letsas KP","year":"2009","unstructured":"Letsas KP, Weber R, B\u00fcrkle G, Mihas CC, Minners J, Kalusche D, Arentz T. Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation. Europace. 2009, 11:158-63. 10.1093\/europace\/eun309","journal-title":"Europace"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.3.4660","article-title":"Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid","volume":"83","author":"Fried SK","year":"1998","unstructured":"Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998, 83:847-50. 10.1210\/jcem.83.3.4660","journal-title":"J Clin Endocrinol Metab"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson TA","year":"2003","unstructured":"Pearson TA, Mensah GA, Alexander RW, et al.. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003, 107:499-511. 10.1161\/01.cir.0000052939.59093.45","journal-title":"Circulation"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.5551\/jat.1735","article-title":"Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis","volume":"17","author":"Spiroglou SG","year":"2010","unstructured":"Spiroglou SG, Kostopoulos CG, Varakis JN, Papadaki HH. Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis. J Atheroscler Thromb. 2010, 17:115-30. 10.5551\/jat.1735","journal-title":"J Atheroscler Thromb"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66585-3","article-title":"\"Vasocrine\" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease","volume":"365","author":"Yudkin JS","year":"2005","unstructured":"Yudkin JS, Eringa E, Stehouwer CD. \"Vasocrine\" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet. 2005, 365:1817-20. 10.1016\/S0140-6736(05)66585-3","journal-title":"Lancet"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000582","article-title":"Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations","volume":"3","author":"Fitzgibbons TP","year":"2014","unstructured":"Fitzgibbons TP, Czech MP. Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations. J Am Heart Assoc. 2014, 3:e000582. 10.1161\/JAHA.113.000582","journal-title":"J Am Heart Assoc"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal2658","article-title":"Detecting human coronary inflammation by imaging perivascular fat","volume":"9","author":"Antonopoulos AS","year":"2017","unstructured":"Antonopoulos AS, Sanna F, Sabharwal N, et al.. Detecting human coronary inflammation by imaging perivascular fat. Sci Transl Med. 2017, 9:10.1126\/scitranslmed.aal2658","journal-title":"Sci Transl Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcct.2019.03.006","article-title":"State-of-the-art review article. Atherosclerosis affecting fat: what can we learn by imaging perivascular adipose tissue?","volume":"13","author":"Antoniades C","year":"2019","unstructured":"Antoniades C, Kotanidis CP, Berman DS. State-of-the-art review article. Atherosclerosis affecting fat: what can we learn by imaging perivascular adipose tissue?. J Cardiovasc Comput Tomogr. 2019, 13:288-96. 10.1016\/j.jcct.2019.03.006","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2014.933685","article-title":"Pericoronary adipose tissue: a novel therapeutic target in obesity-related coronary atherosclerosis","volume":"34","author":"Mazurek T","year":"2015","unstructured":"Mazurek T, Opolski G. Pericoronary adipose tissue: a novel therapeutic target in obesity-related coronary atherosclerosis. J Am Coll Nutr. 2015, 34:244-54. 10.1080\/07315724.2014.933685","journal-title":"J Am Coll Nutr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/496138-peri-coronary-adipose-tissue-attenuation-and-atrial-fibrillation-recurrence-after-catheter-ablation-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T03:09:51Z","timestamp":1787281791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/496138-peri-coronary-adipose-tissue-attenuation-and-atrial-fibrillation-recurrence-after-catheter-ablation-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.114896","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,20]]}}}